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Abstract
Introduction: The role of TLR4 in ischaemic preconditioning is still unclear; we
do not know the change of the expression of TLR4 in the process. In this study,
we used ischaemic preconditioning models to observe the change of TLR4
expression and the level of proinflammatory cytokines TNF-α and IL-1β to
investigate the protective mechanism of TLR4 in ischaemic preconditioning for
myocardial ischaemia-reperfusion injury (MI/RI) in rats. 
Material and methods: Eighteen male Sprague-Dawley (SD) rats were randomly
separated into sham, ischaemic reperfusion (IR) and ischaemic preconditioning
(IP) groups (6/group). Peripheral blood and cardiac muscle with pathological
changes were collected after the establishment of the above three animal
models. We used ELISA to determine proinflammatory cytokines TNF-α and 
IL-1β production in serum of these animals. RT-PCR and Western blot were used
to assay the transcriptional level and protein level of TLR4 in cardiac muscle
tissue with pathological changes, respectively. 
Results: We found that compared with the IR group, ischaemic preconditioning
could effectively reduce the expression levels of TNF-α and IL-1β in sera of rats
in the IP group (p < 0.01). Meanwhile, TLR4 mRNA and protein levels were down-
regulated (p < 0.01 and p < 0.05, respectively). We also found that infarct size
decreased in the IP group compared with the IR group (p < 0.05). 
Conclusions: Based on the results, we can conclude that the specific mechanism
of ischaemic preconditioning for RI might be closely associated with decreasing
expression levels of TLR4 and proinflammatory cytokines such as TNF-α and IL-1β.
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Introduction
Ischaemic heart disease is characterized by reduced blood supply to the
cardiac muscle and is the primary cause of death associated with
myocardial infarction usually occurring as a result of damage induced by
cardiac ischaemia-reperfusion (I/R). Ischaemic preconditioning (IPC) is
a phenomenon by which cyclic episodes of brief I/R protect the
myocardium against subsequent lethal ischaemic injury. It is known to
significantly reduce the infarct size, arrhythmia, and post-ischaemic
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contractile dysfunction [1, 2]. Ischaemic pre  -
conditioning (IPC) is a potent cellular protective
mechanism that is initiated by brief periods of
sublethal ischaemic stress. First identified by Murry
et al., it has been concluded that the heart adapts
within minutes to become resistant against
ischaemia-induced injury. 
The cellular mechanisms underlying the
protection initiated by myocardial IPC have been
scrutinized intensively, given the potential to
identify novel targets for treating ischaemic heart
disease. Work has focused on identifying the
triggers, mediators, and end effectors of IPC.
Numerous signal transduction pathways have been
demonstrated to be mediators affording protection
by IPC. Previous studies have demonstrated that
phosphatidylinositol 3-kinase (PI3K) and its effector
protein kinase B (Akt) are implicated in cell survival
and that acute PI3K/Akt activation underlies the
infarct size (IS)-limiting effect of ischaemic
preconditioning (IP) in the rat heart [3-7]. A recent
studies indicated that toll-like receptors (TLRs) are
involved in the IP process [8, 9].
TLRs represent the first line of host defence
against microbial infection and play a pivotal role
in both innate and adaptive immunity. TLRs
recognize invading pathogens through molecular
pattern recognition, transduce signals via distinct
intracellular pathways involving a unique set of
adaptor proteins and kinases, and ultimately lead
to the activation of transcription factors and
inflammatory responses. Among 10 TLRs identified
in humans, at least two exist in the heart, i.e., TLR2
and TLR4. In addition to the critical role of these in
mediating cardiac dysfunction in septic conditions,
emerging evidence suggests that the TLRs can also
recognize endogenous ligands and may play an
important role in modulating cardiomyocyte survival
and in ischaemic myocardial injury [9]. 
The role of TLR4 in ischaemic preconditioning is
still unclear; we do not know the change of the
expression of TLR4 in the process. In this study we
used ischaemic preconditioning models to observe
the change of TLR4 expression and the level of
proinflammatory cytokines TNF-α and IL-1β.
Therefore, the purpose of this study was to
determine the effect of TLR4 and proinflammatory
cytokines TNF-α and IL-1β that is involved in
ischaemic preconditioning.
Material and methods
Myocardial I/R model and IP model protocol 
Eighteen male Sprague-Dawley (SD) rats were
randomly separated into sham (sham group),
ischaemic reperfusion (IR group) and ischaemic
preconditioning (IP group) groups (6/group). The
I/R model and the surgical protocol were similar to
methods described previously [10-12]. Rats were
anaesthetized with urethane anaesthesia (5 ml/kg
intraperitoneally). Atropine (0.05 mg s.c.) was
administered to reduce airway secretions. Animals
were orally intubated and connected to a mouse
mini-ventilator. Core body temperature was
maintained at 37°C with a heating pad and
monitored with a rectal thermometer. 
A median sternotomy was performed, and the
left anterior descending coronary artery (LAD) was
visualized and completely ligated for 30 min in I/R
mice by tightening an 8-0 silk suture after passing
it over a length of PE-10 tubing beneath the LAD at
points 1-2 mm inferior to the left auricle. The 8-0
suture was similarly placed in the sham group but
without LAD occlusion. The PE-10 tubing was ligated
with the LAD to achieve easier ligature release and
better reperfusion. Ischaemia was confirmed
visually by the appearance of pale and bulging
myocardium in the area at risk (AAR). The ligature
was removed, and reperfusion was visually
confirmed after 30 min of LAD occlusion. IPC was
introduced by three cycles of 5 min ischaemia,
followed by 5 min reperfusion, and repeated four
times. 
Measurement of serum TNF-α and IL-1β level
Serum TNF-α and IL-1β protein levels were
measured by ELISA. Protein was extracted from the
heart by pulverization of frozen tissue followed by
extraction with lysis buffer containing protease
inhibitors. Total protein was determined using
a BCA Protein Assay kit (Pierce, Rockford, Illinois). 
Western blot analysis
Tissue samples from the different groups were
dissected. Tissues were homogenized in 500 ml of
25 mM Tris-HCl (pH 7.4) containing 1% Triton X-100,
0.1% sodium dodecyl sulfate (SDS), 2 mM EDTA, and
1% protease inhibitor cocktail (Sigma) and
centrifuged at 14,0000 g for 30 min at 4°C. The
supernatants were used for Western blot analysis,
with specific antibodies detecting TLR4 (Gen Script).
Enhanced chemiluminescent (ECL) substrate was
from Pierce (Rockford, IL, USA). The polyvinylidene
difluoride (PVDF) membrane was from Schleicher
and Schuell Co. (Hahnestrasse, Dassel, Germany).
According to standard protocols, the blots were
probed with primary antibodies, and horseradish
peroxidase-conjugated secondary antibodies were
used to reveal the specific protein bands with ECL
detection reagents. The intensities of the protein
bands were quantified by densitometry.
RT-PCR analysis
RNA was extracted from fresh rat tissues 
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according to the manufacturer’s instructions. RT-
PCR analysis specific for TLR4 (Forward: 
5’-GGACTCTGCCCTGCCACCATTTA-3’, Reverse: 
5’-CTTGTGC CCTGTGAGGTCGTTGA-3’, anticipated
size of PCR products 2800 bp) and β-actin 
(Forward: 5'-GTCAGAAGGACTCCTACGTG-3', Reverse: 
5'-TAGGAGCCA GGGCAGTAATC-3, anticipated size
of PCR products 825 bp) was then performed using
the RT-PCR kit (Takara Biotechnology) according to
the manufacturer’s instructions.
Determination of myocardial infarct size 
At the end of the perfusion protocols, the
coronary artery was re-occluded and 4 ml of 0.1%
Evans blue dye was injected into the aorta to
delineate the area at risk. Stained hearts were
frozen, sliced, and incubated at 37°C in 1%
triphenyltetrazolium chloride to delineate infarcted
tissue. Slices were then fixed and quantified. Infarct
size was expressed as a percentage of the area at
risk. The area at risk was calculated as a percentage
of the total ventricular area. 
Statistical analysis
Statistical analysis was done using SPSS 10.0.
Parametric data were expressed as mean 
± standard deviation (SD). Comparisons of
parameters among the 3 groups were made with
one-way ANOVA, followed by the Newman-Keuls
test. Comparisons of parameters between 2 groups
were made by unpaired Student's t test. A P value
less than 0.05 was considered statistically sig  -
nificant.
Results
Serum level of TNF-α and IL-1β
There were significant (P < 0.01) differences
observed in the levels of TNF-α and IL-1β between
the I/R group and the sham group (Table I), and the
levels decreased significantly (P < 0.01) in the IP
group compared with the I/R group. The results
showed that ischaemic preconditioning (IPC)
protects the myocardium against lethal ischaemic
injury induced by inflammatory factors TNF-α and
IL-1β.
RT-PCR analysis
The results (Figure 1) showed that the expression
of TLR4 mRNA in the I/R group increased
significantly (p < 0.01) compared with the sham
group, but in the IP group the expression of TLR4
mRNA decreased significantly (p < 0.01) compared
with the I/R group. The results indicated that
ischaemic preconditioning inhibits the expression
of TLR4 mRNA.
Western blot analysis
We found that the expression of TLR4 protein
increased significantly (P < 0.01) in the I/R group
compared with the sham group (Figure 2). There
was no significant (P > 0.05) difference in the
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Figure 1. TLR4 mRNA level determined by RT-PCR
analysis. A – M: marker; line 1-6: sham group; line 
7-12: I/R group; line 13-18: IP group. B – Quantitative
results of TLR4 mRNA. RT-PCR analysis for TLR4 and
β-actin in hearts of different groups. β-actin was
used as an internal loading control
a p < 0.01 vs. sham group, b p < 0.01 vs. I/R group
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]expression of β-actin in the 3 groups. When TLR4
protein levels were normalized with the expression
of  β-actin protein, the ratio was increased
significantly (P < 0.01) in the I/R group compared
with the sham group, whereas in the IP group the
expression of TLR4 protein decreased significantly
(P < 0.01) compared with the I/R group (Figure 2).
These results suggest that TLR4 is activated in I/R,
but ischaemic preconditioning inhibits the process.  
Determination of myocardial infarct size
I/R increased the myocardial infarct size. Infarct
size in the I/R group was greatly increased
compared to the sham group (P < 0.01). As shown
in Figure 3, the infarct size in the I/R group is 0.481
±0.089; in the IP group (0.31 ±0.029) there was
a significant decrease of myocardial infarct size
versus the I/R group (P < 0.05).
Discussion
In our study, we found that the TLR4 protein level
and mRNA level increased in the I/R process; at the
same time TNF-α and IL-1β level increased too. As
we know, the expression of a constitutively active
mutant of human Toll or Toll-like protein in the cell
line activated the NF-κB pathway and the
expression of NF-κB-mediated proinflammatory
cytokines IL-1, TNF-α, and others [13]. We also found
that TLR4 and proinflammatory cytokines IL-1 and
TNF-α levels decreased in the IP process; these
results indicated that the TLR4 signal and
inflammation process are involved in the I/R and IP
process. In addition, we found a significant decrease
of myocardial infarct size in the IP group compared
with the I/R group. So we can conclude that TLR4
and proinflammatory factors TNF-α and IL-1β are
involved in the IP process. To our knowledge, this
is the first study showing that TLR4 and
proinflammatory factors TNF-α and IL-1β decreased
in the IP process.   
Frantz and colleagues first documented that
there was enhanced TLR4 expression in remodelling
murine myocardium remote from sites of ischaemic
injury and in heart tissue from patients with
idiopathic dilated cardiomyopathy [14]. In animal
models of ischaemia-reperfusion injury or in hypoxic
cardiomyocytes in vitro, the administration of
a sublethal dose of lipopolysaccharide, which signals
through TLR4, reduces subsequent myocardial
infarction, improves cardiac functions, and
attenuates cardiomyocyte apoptosis [15, 16]. By
contrast, a systemic deficiency of TLR4 leads to
attenuated myocardial inflammation, a smaller
infarction size, better preserved ventricular function,
and reduced ventricular remodelling after ischaemic
injury [17, 18]. These recent studies demonstrate an
emerging role for TLRs as a critical modulator in
both cell survival and tissue injury in the heart. The
precise molecular mechanisms responsible for the
phenomenon are still unclear.
In summary, we found that the expression of
TLR4 gene and protein decreased in the IP process.
The preliminary data need to be well discussed and
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Figure 2. TLR4 protein level determined by Western blot. A – β-actin was used as an internal control to monitor equal
protein sample loading. The expression of TLR4 was markedly increased in the I/R group compared with the sham
control group. In the IP group there was attenuated expression of TLR4. B – Quantitative results of TLR4. Mean density
of TLR4 in sham-operated group was defined as 100%
n = 6, mean ± SD, a p < 0.01 vs. sham group, b p < 0.01 vs. I/R group
Figure 3. Determination of myocardial infarct size.
Infarct size of I/R group is 0.481 ±0.089; in the IP
group (0.31 ±0.029) there was a significant decrease
of myocardial infarct size vs. the I/R group 
b P < 0.05
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further studies carried out. It is possible that further
studies of TLR4 will provide clues for better
understanding of its function and may help uncover
novel therapeutic strategies for regulating the I/R
and IP process.
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